IPA (International Pharmaceutical Abstracts)
Subject
Coverage

Topics related to pharmaceuticals and the pharmaceutical industry, ranging frompharmaceutical chemistry and technology, to legislation and regulations, to the sociology,economics and ethics of drugs. Specifically, the topics include:• Adverse Drug Reactions and Toxicity• Microbiology• Biopharmaceutics and Pharmaceutics• Pharmacognosy• Cosmetics• Pharmaceutical Education• Drug Evaluations and Interactions• Pharmaceutical Technology• Drug Metabolism and Body Distribution• Pharmacology and PharmaceuticalChemistry• Drug Stability• Pharmacy Practice• Environmental Toxicity• Preliminary Drug Analysis and Testing• History• Related Health Topics• Information Processing• Sociology and Economics and Ethics of• Institutional Pharmacy PracticeDrugs• Investigational Drugs• Legislation and Regulations

File Type

BibliographicFeatures

Thesaurus

Controlled term (/CT) field

Alerts (SDI)

Twice a month or monthly (default)

CAS Registry
Number® IdentifiersPage Images

Keep & Share

SLART

Learning Database

RecordContent••••••

File SizeMore than 753,130 records (02/23)

Coverage

1970-presentUpdates

Twice a month

Language

EnglishStructures

STN Easy®

Bibliographic data
Abstracts
Indexing terms
Chemical names, abstracts
CAS Registry Numbers®
An online thesaurus is also available to help locate controlled vocabulary index terms.

February 2023

2IPA

Database
Producer

Clarivate Analytics (UK) Limited
Friars House, 160 Black Friars Rd.
London SE1 8EZ
United Kingdom
Phone: +44-20-7433-4000
Fax:+44-20-7433-4001
Helpdesk:+44-20-7433-4999
Clarivate Analytics
1500 Spring Garden Street
Philadelphia, PA 19130 USA
Phone: 800-336-4474
Fax:215-386-2911
http://science.thomsonreuters.com
Clarivate Analytics
Palaceside Bldg. 5F
1-1-1 Hitotsubashi
Chiyoda-ku
Tokyo 100-0003
Japan
Phone: 3 5218 6500
Fax:
3-5218-7840
http://science.thomsonreuters.com.jp
Copyright Holder: Clarivate Analytics. For
more information on Clarivate Analytics Termsof Business visit http://clarivate.com/tob/.

SourcesInternational Pharmaceutical Abstracts covering approximately 750 journals worldwide
and all U.S. state pharmacy journals. Abstracts include information from:• Abstracts• Notes• Bulletins• Presentations• Editorials• Reviews• Journal articles• Translations• Meetings

User Aids• Online Helps (HELP DIRECTORY lists all help messages available)• STNGUIDEClusters• ALLBIB• AUTHORS• CASRNS• CHEMISTRY• CORPSOURCE• FORMULATIONS• HEALTH• MEDICINE• PHARMCOLOGY• TOXICOLOGYSTN Database Clusters information (PDF).

PricingEnter HELP COST at an arrow prompt (=>).

February 2023

3IPA

Search and Display Field Codes
There are no fields that allow left truncation in this file.
Search Field Name

SearchCodeDisplay
Codes

Search Examples

Basic Index (contains single words
from the title (TI), controlled term(CT), abstract (AB), index term(IT), and chemical name (CN)fields, as well as CAS Registry
Numbers (RN))

None(or /BI)S 302-79-4
S PREGNAN? (P) TRETINOINS RETIN-A/BI

AB, CN, CT, IT,RN

Accession Number/AN

ANAuthor
Chemical Name (includes names
from the CN and RN fields)
Classification Code (1)(code and text)

/AU
/CN

S 92:419/AN
S 1998:1234/AN
S CAMERA, M?/AU
S RETIN-A/CN

CC

Controlled Term (2)/CT

Controlled Word
Corporate Source (1)Document Number
Document Type (code and text)/CW/CS/DN/DT(or /TC)/ED(or /UP)/FA/FS/ISNS TOPICAL PREPARATIONS/CCS TOPICAL/CC
S "CATHARTICS AND LAXATIVES"/CC
S 28/CCS 28:08/CC
S 28:08.04/CC
S CARDIAC DRUG#/CT
S A-16686+ALL/CT
S L2 AND DOMIODOL/CWS DIV OF CARDIOL?/CS
S 29-05774/DN
S L4 AND CONFERENCE/DT
S L4 AND C/DT
S L2 AND ED>=20000100
S L4 AND AB/FA
S AORTA AND HUMAN/FSS LANCAO/ISN
S 0023-7507/ISN

Not displayed
FS
ISN, SO/JT

S US PHARM/JT

JT, JTA, JTF, SO/LAS ENGLISH/LA AND L1
S EN/LA AND L1
S PD>19990600
S 1999-2000/PYS TOXICITY/SC
S 4/SCS (THERAP? AND VOL 21)/SOLAS JAPANESE/SL
S JA/SLS (PREGNAN? AND VITAMIN#)/TI

SL

Entry Date (3)Field Availability
File Segment (code and text)
International Standard (Document)
Number (contains ISSN andCODEN)
Journal Title (contains full andabbreviated journal titles)
Language (code and text)/CC

Publication Date (3)Publication Year (3)Section (code and text) (1)

/PD
/PY
/SC

Source (contains full andabbreviated journal titles,
publication dates, collation
information (volume, issue,pagination), CODEN, and ISSN)
Summary Language (code and text)/SOTitle/TI/SLAU
CN, RNCT, ITCT, ITCS
DNDT
Not displayed

PD, SOPY, SOSCSOTI(1) Search with implied (S) proximity is available in this field.
(2) There is a thesaurus associated with this field.
(3) Numeric search field that may be searched with numeric operators or ranges.

February 2023

4
IPA

Controlled Term (/CT) Thesaurus
All relationship codes may be used with the SEARCH and EXPAND command in the Controlled Term (/CT)
field.
CodeALL

ContentAll associated terms(SELF, OLD, USE, UF, RT)
Keyword Terms (Multiword phrases that
contain the term (SELF, KT)
Preferred and Forbidden Terms(SELF, USE, UF)
Related terms(SELF, RT)
Used For (forbidden) terms(SELF, UF)
Use (preferred) terms(SELF, USE)KT
PFTSTDUF
USE

Thesaurus Field Descriptors
CodeSELF
KT
OLD
RT
UF
USE

February 2023

Description
Term
Keyword Term
Old Preferred Term
Related Term
Used For
Use

ExamplesE TRAGACANTH+ALL/CT
E TOXICITY+KT/CT
E POLLUTION+PFT/CT
E DRUGS, ADVERSE REACTIONS+STD/CTE HYDROCHLOROTHIAZIDE+UF/CT
E ORETIC+USE/CT5IPA

DISPLAY and PRINT Formats
Any combination of display formats may be used to display or print answers. Multiple codes must be
separated by spaces or commas, e.g., D L1 1-5 TI AU; D L1 1-5 TI,AU. The fields are displayed in the orderrequested.
Hit-term highlighting is available in all fields except CT and PY. Highlighting must be on during SEARCH inorder to use the HIT, KWIC, and OCC display formats.
FormatContentExamplesAB
AN (1)AU
CC (1)
CN (1)CSCT (1,2)
DNDT
FS (1)ISN (2)IT (1)
JT (2)JTA (2)
JTF (2)
LAPD (2)PY (2)
RN (1)SC (1)SLSO
TC (2)
TI (1)

Abstract
Accession NumberAuthor
Classification Code
Chemical Name
Corporate Source
Controlled Term
Document Number
Document Type
File Segment
International Standard (Document) Number
Index Term
Journal Title
Journal Title, Abbreviated
Journal Title, Full
Language
Publication Date
Publication Year
CAS Registry Number
SectionSummary Language
SourceTreatment CodeTitle

D L4 1-4 AB
D L1 3 AN
D AU 1,3-5
D CC 5-10
D 1-3,7,8 CN
D CS
D 1 4 CTD DN 1-5D L1 DT 3
D 1,3,6 FS L5
D ISN
D IT 1,4 7
D JT 2
D JTA 2
D JTF 2
D L8 LA 1-3
D L1 PD
D PY
D RN L1 4
D SC 1-3
D SL 3,4
D SO 3 6
D TC
D TIABS
ALLBIB
CBIB
IALL
IBIB
IND (1)
SAM (1)
SCAN (1,3)

AB
AN, DN, TI, AU, CS, SO, DT, FS, LA, SL, AB, SC, CC, IT, RN, CN
AN, DN, TI, AU, CS, SO, DT, FS, LA, SL (BIB is the default)
AN, DN, compressed Bibliographic Data
ALL, indented with text labels
BIB, indented with text labels
SC, CC, IT, RN, CN
TI, SC, CC, IT, RN, CN
TI, SC, CC, IT, RN, CN (random display without answer numbers)

D ABS
D ALL
D BIB L2 5
D CBIB 1 3
D IALLD IBIB
D TI IND
D SAM TOTALD SCANHITKWICOCC (1)

Fields containing hit terms
Hit terms with 20 words on either side (KeyWord-In-Context)
Number of occurrences of hit terms and fields in which they occur

D HIT 1 5
D 1-7 KWIC NOH
D OCC(1) No online display fee for this format.
(2) Custom display only.
(3) SCAN must be specified on the command line, i.e., D SCAN or DISPLAY SCAN.

February 2023

6IPA

SELECT, ANALYZE, and SORT Fields
The SELECT command is used to create E-numbers containing terms taken from the specified field in ananswer set.
The ANALYZE command is used to create an L-number containing terms taken from the specified field in ananswer set.
The SORT command is used to rearrange the search results in either alphabetic or numeric order of thespecified field(s).
Field Name
Abstract
Accession NumberAuthor
CAS Registry Number
Chemical Name
Chemical Name and CAS Registry Number
Classification Code
CODEN
Controlled Term
Corporate Source
Document Number
Document Type
File Segment
Index Term
International Standard (Document) Number
International Standard Serial Number
Journal Title
Journal Title, Abbreviated
Journal Title, Full
Language
Occurrence Count of Hit Terms
Publication Date
Publication Year
SectionSourceSummary Language
Title
Treatment CodeField CodeANALYZE/SELECT (1)

SORT

AB
AN
AU
RN
CN
NAME
CHEM
CC
CODEN
CT
CS
DN
DT
FS
IT
ISN
ISSN
JT
JTA
JTF
LA
OCCPDPYSCSO
SLTI
TCY (2)
YY
Y (2,3)
Y
Y (2)
Y (2)
YNY (3)YY
YYY (2)Y (4)
NY (5)YYYNYY (3)YY (6)YY (default)
YNNYNNNNYYNYYYYNNYYYYYYYYYNY
YY(1) HIT may be used to restrict terms extracted to terms that match the search expression used to create the answer set, e.g., SEL HITTI.
(2) Appends /BI to the terms created by SELECT.
(3) SELECT HIT and ANALYZE HIT are not valid with this field.
(4) Selects or analyzes the CODEN and ISSN with /ISN appended to the terms created by SELECT.
(5) Selects or analyzes the full and abbreviated titles with /JT appended to the terms created by SELECT.
(6) Selects or analyzes the CODEN and ISSN with /SO appended to the terms created by SELECT.

February 2023

7IPASample Records
DISPLAY IALLACCESSION NUMBER:
DOCUMENT NUMBER:
TITLE:AUTHOR:
CORPORATE SOURCE:
SOURCE:DOCUMENT TYPE:LANGUAGE:
ABSTRACT:SECTION:
CLASSIFICATION:INDEX TERM:
INDEX TERM:
INDEX TERM:
INDEX TERM:
INDEX TERM:
INDEX TERM:
INDEX TERM:
INDEX TERM:
INDEX TERM:
INDEX TERM:
CAS REGISTRY NO.:CAS REGISTRY NO.:CAS REGISTRY NO.:CHEMICAL NAME:

2000:9274 IPA
37-09275
Flurbiprofen loaded poly-epsilon-caprolactone
nanospheres: in vitro release study performed under
several conditions
Gamisans, F.; Egea, M. A.; Garcia, M. L.; Lacoulonche,F.; Chauvet, A.
Lab. de Chimie Minerale et Gen., Fac. de Pharm, 34060
Montpellier, France
Journal of Controlled Release (Netherlands), (Feb 142000) Vol. 64, pp. 315-318. 13 Refs.
CODEN: JCREEC; ISSN: 0168-3659.
Conference
EnglishNanospheres of poly(epsilon-caprolactone)(poly-epsilon-caprolactone)
loaded with flurbiprofen were prepared and characterized, and invitro drug release from the nanospheres, in the presence and absenceof lysozyme(muramidase), was studied using a dialysis bag diffusion
technique and a dialysis inverse technique. The results showed thatthe release of flurbiprofen from the nanospheres was biphasic,characterized by an initial fast-release phase and a second
extended-release phase. In the presence of lysozyme, therelease of flurbiprofen was slower but complete. Ramune T. Dailide
9 Pharmaceutics; 10 Drug Stability
28:08.04 Anti-inflammatory agents; 44:00 Enzymes
Flurbiprofen; release; nanospheres
Poly(epsilon-caprolactone); nanospheres; flurbiprofen
Lysozyme; incompatibilities; flurbiprofen
Anti-inflammatory agents; flurbiprofen; release
Release; flurbiprofen; nanospheres
Nanospheres; flurbiprofen; release
Enzymes; lysozyme; incompatibilities
Incompatibilities; lysozyme and flurbiprofen; release
Incompatibilities; flurbiprofen and lysozyme; release
Sustained-action medications; flurbiprofen; release5104-49-4 (Flurbiprofen)
24980-41-4 (Poly(epsilon-caprolactone))
9001-63-2 (Lysozyme)
Poly(epsilon-caprolactone) (Poly-epsiloncaprolactone); Lysozyme (Muramidase)

DISPLAY BIB
ANDN
TIAU
CSSODTLA

2000:9532 IPA
37-09533
Antibiogram development for an outpatient dialysis center
Manley, H. J.; Bailie, G. R.; Neumann, M.
Albany Coll. of Pharm., 106 New Scotland Ave., Albany, NY 12208, USA
Internet: bailieg@acp.edu
Hospital Pharmacy (USA), (Mar 2000) Vol. 35, pp. 251-253. 12 Refs.
CODEN: HOPHAZ; ISSN: 0018-5787.
JournalEnglishFebruary 2023

8IPA

In North America

In EMEAIn Japan

CAS Customer Center
P.O. Box 3012
Columbus, Ohio 43210-0012
U.S.A.

CAS Customer Center EMEA
(represented by FIZ Karlsruhe)
P.O. Box 2465
76012 Karlsruhe
Germany

JAICI (Japan Association forInternational Chemical Information)
Nakai Building
6-25-4 Honkomagome, Bunkyo-ku
Tokyo 113-0021
Japan

Phone:

800-753-4227 (North America)
614-447-3731 (worldwide)
Email:
help@cas.org
Internet: www.cas.org

Phone: +49-7247-808-555
E-mail: EMEAhelp@cas.org

Phone:+81-3-5978-3601 (Technical Service)+81-3-5978-3621 (Customer Service)support@jaici.or.jp (Technical Service)customer@jaici.or.jp (Customer Service)
Internet: www.jaici.or.jp
Email:

February 2023